News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Full results and Plain Language Summary for CheckMate 77T trial – NEJM
Photo of NEJM from tukuz.com
May 28, 2024, 07:48

Full results and Plain Language Summary for CheckMate 77T trial – NEJM

NEJM shared on X/Twitter:

“In the CheckMate 77T trial, researchers assessed whether adding adjuvant nivolumab to neoadjuvant nivolumab plus chemotherapy would improve outcomes in patients with resectable non–small-cell lung cancer (NSCLC). Full results and Plain Language Summary.”

Perioperative Nivolumab in Resectable Lung Cancer A PLAIN LANGUAGE SUMMARY Top Figure: Illustration of treatment options during the Neoadjuvant and Adjuvant Periods. Bottom Figure: Graph of the Percentage of Patients with Event-free Survival

Source: NEJM/X

adjuvant nivolumab cancer CheckMate 77T trial NEJM neoadjuvant nivolumab OncoDaily Oncology resectable NSCLC
Special Coverage
Blog
Feb 18, 2025, 15:20
Kimryn Rathmell: In a time when things are changing fast, having other ways to distill the information is vital
Blog
Feb 18, 2025, 14:55
Registration is open for the MASCC Pediatrics Supportive Care Share
Insight
Feb 18, 2025, 14:51
Nils Eckardt: Navigating the Information Maze
Blog
Feb 18, 2025, 14:44
Tanja Obradovic: Another step in the global move toward value-based therapeutic options
Blog
Feb 18, 2025, 14:40
Dana-Farber Cancer Institute joined the international Alliance for Cancer Early Detection
Blog
Feb 18, 2025, 14:23
Lisa Lacasse: Having comprehensive, affordable health insurance is a major determining factor in surviving cancer
Blog
Feb 18, 2025, 14:15
Alique Topalian: The biomarker bill has been reintroduced for the third time
Insight
Feb 18, 2025, 14:05
Matthew Oberley: Characterization of plasma cfDNA variants as of tumor- or clonal hematopoiesis-origin
Blog
Feb 18, 2025, 14:04
Mohammed Ibrahim: The Royal Marsden - a world-renowned hub for cancer care and research
Blog
Feb 18, 2025, 13:59
Ulrika Årehed Kågström: Grateful to take part in this year’s Global NCD Alliance Forum in Kigali
Blog
Feb 18, 2025, 13:58
Palliative Care Practice in Africa - Kenyan Network of Cancer Organizations
Science
Feb 18, 2025, 12:52
Yan Leyfman: A new computational tool to study gene regulation in cellular differentiation